Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |